Stockreport

Acadia Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operating Overview

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF - Third quarter total revenues of $278.6 million, up 11% year-over-year- Narrowing and raising high end of NUPLAZID® net product sales guidance to $685 to $695 million- [Read more]